Capacity Bio is developing the most comprehensive and advanced mitophagy therapeutics and development platform for the purpose of restoring mitochondria quality control in disease.


Our lead focus is neurodegeneration and muscular disorders, including Parkinson’s, ALS, and DMD which targets multibillion opportunities.


Capacity Bio has a unique set of drugs that improve mitochondrial quality control by targeting receptors on the cell surface.


  • Engage target quickly and efficiently
  • No need to enter the cell or mitochondria
  • Safe and effective

    Development Stage:

    • Pre-clinical

    Patents Pending:

    • Coming Soon


      Website: Phone: (310) 880-6414 Email: LinkedIn